Paul M. Silva, SVP & Interim CFO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 5,464 shares at $187.10 ($1.0M) on 2019-02-19, disclosed to the SEC on 2019-02-21.
Seasonal sale ($1.0M) by SVP & Interim CFO — this insider has traded VRTX in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $186.72 | 1,668 | $311K | 30.5% |
| 2 | $186.72 | 1,668 | $311K | 30.5% |
| 3 | $187.10 | 984 | $184K | 18.0% |
| 4 | $187.10 | 984 | $184K | 18.0% |
| 5 | $188.70 | 160 | $30K | 3.0% |
| Total | $186.91 avg | 5,464 |
| $1.0M |
| 100% |
| Filing → |
| VRTX | SELL | 2021-02-19 | $1.8M | — | Filing → |
| VRTX | SELL | 2021-02-16 | $586K | — | Filing → |
| VRTX | SELL | 2020-08-10 | $564K | — | Filing → |